-
CCRM is excited to launch a brand new initiative. We are answering your Qs on a variety of topics related to
#CARTs#CGTs#GMP working with#CDMOs...and if you don't know these acronyms, you should definitely check it out! https://www.ccrm.ca/cdmo_education_centre …#Biotechnology#STEMpic.twitter.com/aad829JLKi -


#countdown#Christmas#53Biologics Our#mission is to provide#services to different companies, from start-ups to large companies, as well as to other#CDMOs, to help their products to reach the market#pharma#biotecnology#biotech#microbiologypic.twitter.com/IvEvlubW46
-
We are so very proud to share the news about our
#FDA approval!! This achievement positions us at the level of the most distinguished#CDMOs in the world and represents a very important breakthrough in the history of 3P. https://www.3pbio.com/2019/09/18/3p-biopharmaceuticals-receives-fda-approval/ … pic.twitter.com/RfExhOFPxR
-
Pharma
#CDMOS: long time veteran observer and good friend Jim Miller reflects on 20+ years’ learnings at#PBOACON19@PBOAssocpic.twitter.com/AM6hVZ8XHL
-
Lack of good
#CDMOs a factor for@KrystalBiotech in investing $70-90m into internal PA gene therapy plant https://buff.ly/2Obgc1e pic.twitter.com/wqhhN650eL
-
It's important for
#CDMOs to be fully transparent when it comes to audits to ensure the correct quality is achieved. Read more: https://bit.ly/2Fi7au7 via@OutsourcedPharm -
"Fear of innovation in the East will drive innovation in the West." Do Western CMOs need to 'up their game' to combat an increasingly Eastern-facing market? Read our latest article
https://bit.ly/2Z0t8JQ
#CMOs#CDMOs#pharma#pharmaceuticals#innovation#NCEspic.twitter.com/0hpijXCKK5 -
The value
#CROs and#CDMOs bring, especially smaller, focused biotechs can sometimes be overlooked. However, a strong symbiotic relationship between companies and their partners is critical to bring new therapies to market. Thanks@Louis_Garguilo!https://www.lifescienceleader.com/doc/i-outsource-therefore-i-exist-0001?vm_tId=2114446&user=57be9c65-5ff3-47de-870a-30bb98fe8e4b&vm_alias=I%2520Outsource,%2520Therefore%2520I%2520Exist&utm_source=mkt_LSL&utm_medium=email&utm_campaign=LSL_03-04-2019&utm_term=57be9c65-5ff3-47de-870a-30bb98fe8e4b&utm_content=I%2520Outsource,%2520Therefore%2520I%2520Exist&mkt_tok=eyJpIjoiT0dJNVltVXlaV1kxT0dGaiIsInQiOiIrWXJxVmN3ejM1c2lhM21tRkJVc1wvRHpJdm5tVFZwRThEY01YU0M4OUcwZ0N2UDB0dlJ3allUTExkeDJzaCt1UjNtaG5WTXdFbHNLV014UGtZbDdqeUNHMUF5ekZBRzRJOXpZdWZZMVJ5UE94cVhHRkpWbzVHWTBSUkkzdEYzajEifQ%253D%253D … -
Read a first-hand report by the
@Siegfried_Group about the#opportunities for Western#CDMOs in China https://twitter.com/CHEManager_EU/status/1069522909088092160 …
-
Ready to use next-gen technology platforms and shift in portfolios from large volumes but simple, to lower volumes but complex or orphan molecules or even the lack of approved capacity for complex/sterile drugs are some reasons the
#CDMOs have started to feel real +ve traction.Prikaži ovu nit -
Outsourced Pharma’s
@Louis_Garguilo pulls out the Big Take-Home messages from the 2018@dcatorg Benchmarking Survey examining the current & future alignment of the#pharma customer–supplier relationship#CDMOs#outsourcedpharmahttps://twitter.com/Louis_Garguilo/status/1092400554356162560 … -
In order to capitalize on the trend to outsource product development and manufacturing,
#CDMOs need to continuously optimize their#commercial strategy by establishing and enforcing a value-based pricing concept. Our experts commented for@CHEManager_EU. http://bit.ly/2QfKNhC pic.twitter.com/Fb993Psw9r
-
Maurits Janssen of
#Lonza explains how#pharma companies &#CDMOs should respond to the rapidly evolving#HPAPI landscape with efficient + detailed containment procedures – in@CRTmagazine. Read the full story http://ow.ly/pSBA30mWc6G@LonzaGrouppic.twitter.com/LA68lCVDIx
-
Although pharmaceutical companies choose to
#outsource for different reasons, many businesses work with CROs, CMOs and#CDMOs because it can reduce the overall cost and risk of their project. Explore the other factors driving a surge in outsourcing here: https://bit.ly/32gaC1Z pic.twitter.com/U3fTaoXABL
-
"Outsourcing is a very effective way for pharma companies to tap into additional formulation expertise.” Our Global VP Innovator Products and Solutions, Nick Shackley, examines the growing partnership between
#CDMOs and#Pharma in@medicine_maker: https://bit.ly/2E6DcK1 pic.twitter.com/KSObEAxEMA
-
From heightened manufacturing and sourcing additional storage to lengthening best before dates, there are many challenges facing
#CDMOs to stockpile 6 weeks worth of#medicine in the case of a no deal Brexit. Read more about these challenges, here: http://ow.ly/YfAa30mTfju pic.twitter.com/r99q34p54J
-
#BioIntegrates is tomorrow! We're sold out with lots of great speakers and insightful panel discussions. Registration is from 8am so see you then! https://www.lifescienceintegrates.com/bio-integrates-agenda-2019/ …#lifesciences#biotech#CDMOs#CROs#pharmapic.twitter.com/6JuAJYW21V
-
David Enloe, CEO at Ajinomoto Bio-Pharma Services was recently interviewed for Outsourced Pharma's From the Editor article. In it, he discusses the value of and need for
#CDMOs and biopharma to form trusted partnerships. https://www.outsourcedpharma.com/doc/business-roundtable-reaffirms-capitalism-and-the-supply-chain-0001 …#biopharma#partnerships -
Sai Life Sciences, one of India's fastest growing Contract Development & Manufacturing Organizations (CDMOs)
#Lifesciences#Jaystella#KrishnaKanumuri#pharmaceutical#Research#development#CDMOs#medicircle#healthcare#Infrastructurehttps://bit.ly/2Pw6vM4 -
Cultivating brand advantage for
#CDMOs http://ow.ly/3lWR30neDgl#pharma#outsourcing@ColeyPorterBell#brand
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.